Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
H9N2 subtype low pathogenicity avian influenza virus (LPAIV) is distributed worldwide and causes enormous economic losses in the poultry industry. Despite immunization of almost all chickens with inactivated vaccines, the disease still remains widespread. We speculated that improving mucosal or cell...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105734/ https://www.ncbi.nlm.nih.gov/pubmed/32266297 http://dx.doi.org/10.3389/fvets.2020.00153 |
_version_ | 1783512462317846528 |
---|---|
author | Sha, Zhou Shang, Hongqi Miao, Yongqiang Huang, Jin Niu, Xiangyun Chen, Ruichang Hu, Liping Huang, He Wei, Kai Zhu, Ruiliang |
author_facet | Sha, Zhou Shang, Hongqi Miao, Yongqiang Huang, Jin Niu, Xiangyun Chen, Ruichang Hu, Liping Huang, He Wei, Kai Zhu, Ruiliang |
author_sort | Sha, Zhou |
collection | PubMed |
description | H9N2 subtype low pathogenicity avian influenza virus (LPAIV) is distributed worldwide and causes enormous economic losses in the poultry industry. Despite immunization of almost all chickens with inactivated vaccines, the disease still remains widespread. We speculated that improving mucosal or cellular immune responses could contribute to improved control of H9N2 viruses. In this study, we constructed a novel Lactococcus lactis (L. lactis) strain expressing a recombinant fusion protein consisting of the M1 and HA2 proteins derived from an antigenically conserved endemic H9N2 virus strain. The M1-HA2 fusion protein was cloned downstream of a gene encoding a secretory peptide, and we subsequently confirmed that the fusion protein was secreted from L. lactis by Western blotting. We assessed the immunogenicity and protective effects of this recombinant L. lactis strain. Eighty 1-day-old chickens were divided into four groups, and the experimental groups were orally vaccinated twice with the recombinant L. lactis strain. Fecal and intestinal samples, sera, and bronchoalveolar lavage fluid were collected at 7, 14, and 21 days post-vaccination (dpv). Chickens vaccinated with the recombinant L. lactis strain showed significantly increased levels of serum antibodies, T cell-mediated immune responses, and mucosal secretory IgA (SIgA). Following challenge with H9N2 virus at 21 dpv, chickens vaccinated with the recombinant L. lactis strain showed decreased weight loss, lower viral titers in the lung, and reduced lung pathological damage. In summary, our results demonstrated that a recombinant L. lactis strain expressing an H9N2 M1-HA2 fusion protein could induce protective mucosal and systemic immunity. This oral vaccine is H9N2 virus-specific and represents a significant design improvement compared with previous studies. Our study provides a theoretical basis for improving mucosal immune responses to prevent and control H9N2 virus infection. |
format | Online Article Text |
id | pubmed-7105734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71057342020-04-07 Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens Sha, Zhou Shang, Hongqi Miao, Yongqiang Huang, Jin Niu, Xiangyun Chen, Ruichang Hu, Liping Huang, He Wei, Kai Zhu, Ruiliang Front Vet Sci Veterinary Science H9N2 subtype low pathogenicity avian influenza virus (LPAIV) is distributed worldwide and causes enormous economic losses in the poultry industry. Despite immunization of almost all chickens with inactivated vaccines, the disease still remains widespread. We speculated that improving mucosal or cellular immune responses could contribute to improved control of H9N2 viruses. In this study, we constructed a novel Lactococcus lactis (L. lactis) strain expressing a recombinant fusion protein consisting of the M1 and HA2 proteins derived from an antigenically conserved endemic H9N2 virus strain. The M1-HA2 fusion protein was cloned downstream of a gene encoding a secretory peptide, and we subsequently confirmed that the fusion protein was secreted from L. lactis by Western blotting. We assessed the immunogenicity and protective effects of this recombinant L. lactis strain. Eighty 1-day-old chickens were divided into four groups, and the experimental groups were orally vaccinated twice with the recombinant L. lactis strain. Fecal and intestinal samples, sera, and bronchoalveolar lavage fluid were collected at 7, 14, and 21 days post-vaccination (dpv). Chickens vaccinated with the recombinant L. lactis strain showed significantly increased levels of serum antibodies, T cell-mediated immune responses, and mucosal secretory IgA (SIgA). Following challenge with H9N2 virus at 21 dpv, chickens vaccinated with the recombinant L. lactis strain showed decreased weight loss, lower viral titers in the lung, and reduced lung pathological damage. In summary, our results demonstrated that a recombinant L. lactis strain expressing an H9N2 M1-HA2 fusion protein could induce protective mucosal and systemic immunity. This oral vaccine is H9N2 virus-specific and represents a significant design improvement compared with previous studies. Our study provides a theoretical basis for improving mucosal immune responses to prevent and control H9N2 virus infection. Frontiers Media S.A. 2020-03-24 /pmc/articles/PMC7105734/ /pubmed/32266297 http://dx.doi.org/10.3389/fvets.2020.00153 Text en Copyright © 2020 Sha, Shang, Miao, Huang, Niu, Chen, Hu, Huang, Wei and Zhu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Sha, Zhou Shang, Hongqi Miao, Yongqiang Huang, Jin Niu, Xiangyun Chen, Ruichang Hu, Liping Huang, He Wei, Kai Zhu, Ruiliang Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens |
title | Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens |
title_full | Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens |
title_fullStr | Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens |
title_full_unstemmed | Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens |
title_short | Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens |
title_sort | recombinant lactococcus lactis expressing m1-ha2 fusion protein provides protective mucosal immunity against h9n2 avian influenza virus in chickens |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105734/ https://www.ncbi.nlm.nih.gov/pubmed/32266297 http://dx.doi.org/10.3389/fvets.2020.00153 |
work_keys_str_mv | AT shazhou recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT shanghongqi recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT miaoyongqiang recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT huangjin recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT niuxiangyun recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT chenruichang recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT huliping recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT huanghe recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT weikai recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens AT zhuruiliang recombinantlactococcuslactisexpressingm1ha2fusionproteinprovidesprotectivemucosalimmunityagainsth9n2avianinfluenzavirusinchickens |